RH
Roche Holding AG
RHHBF · OTC
$419.92 -0.00% (-$0.00)
1M -6.68%
Market Cap CHF 278.1B
P/E Ratio 21.58x
Div. Yield 2.95%
ROE 40.66%
Bulios Fair Price
$357.74
14.8% downside
Current Price
$419.92
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RHHBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
55 /100
Fair P/E 21.58x
PEG 0.39x
EV/EBITDA 13.54x
Growth
27 /100
Declining EPS growth 1.45%
Book val. growth 6.51%
Rev. growth 0.92%
Profitability
100 /100
Strong Gross margin 72.94%
FCF margin 22.89%
Net margin 20.94%
Quality
88 /100
Excellent ROIC 17.22%
Asset turnover 0.61x
ROE 40.66%
Debt
73 /100
Low Debt/Equity 1.02x
Net debt/EBITDA 1.27x
Current ratio 1.38x
Stability
70 /100
Stable Beta 0.38x
Profitable years 6
Rev. volatility 3.88%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RHHBF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
Employees
103,249
Headquarters
Basel
Upcoming events
04 FEB
Earnings
Upcoming earnings report